Reference
Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 Billion. Internet Document : 7 Jul 2015. Available from: URL: http://dx.doi.org/10.1377/hlthaff.2014.1274
Rights and permissions
About this article
Cite this article
PCV13 expected to save $US billions over a decade. PharmacoEcon Outcomes News 732, 25 (2015). https://doi.org/10.1007/s40274-015-2291-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2291-7